[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 972
Citations 0
Correction
August 2015

Error in Figure

JAMA Neurol. 2015;72(8):950. doi:10.1001/jamaneurol.2015.1752

In the Original Investigation titled “Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple Sclerosis” published online February 9, 2015, and in the April 2015 print issue of JAMA Neurology,1 an error occurred in Figure 3. In part B, the 2 curves, which should originate at zero on both axes, were inadvertently shifted up to originate above zero on the y-axis. The online and print versions of the article were corrected before publication of the April issue, but the online PDF of the article was not. This article’s online PDF was corrected.

References
1.
He  A, Spelman  T, Jokubaitis  V,  et al; MSBase Study Group.  Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis. JAMA Neurol. 2015;72(4):405-413.
PubMedArticle
×